The content is available as a PDF (353.6 KB).
letter . 2020 Aug 4:jfaa133. doi: 10.1093/jalm/jfaa133
Cross-Comparison of a Chemiluminescent Platform and a Commercial Receptor Binding Domain-Based ELISA Assay for Detecting SARS-CoV-2 IgG
Thessicar Antoine-Reid
1, James Malone
1, Alexander S Maris
1, Jill White-Abell
1, Jonathan E Schmitz
1,✉
Thessicar Antoine-Reid
1Diagnostic Laboratories and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Find articles by Thessicar Antoine-Reid
James Malone
1Diagnostic Laboratories and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Find articles by James Malone
Alexander S Maris
1Diagnostic Laboratories and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Find articles by Alexander S Maris
Jill White-Abell
1Diagnostic Laboratories and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Find articles by Jill White-Abell
Jonathan E Schmitz
1Diagnostic Laboratories and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Find articles by Jonathan E Schmitz
1Diagnostic Laboratories and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
✉
Address correspondence to this author at: Jonathan E. Schmitz, 1301 Medical Center Drive, Suite 4519 The Vanderbilt Clinic, Nashville, TN 37232 USA, 615-343-1289 (T), 615-322-2504 (F), jonathan.e.schmitz@vumc.org
Received 2020 Jun 23; Revised 2020 Jul 15; Accepted 2020 Jul 21.
Keywords: COVID-19, SARS-CoV-2, Serology, IgG, Abbott Architect
© 2020 American Association for Clinical Chemistry
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7454603 PMID: 32750140